Skip to content

Treatment of Social Phobia and Panic Disorder in Adults

A Randomized, Controlled Study of a Stepped-care Model for the Treatment of Social Phobia and Panic Disorder in Adults

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00619138
Acronym
TSPPA
Enrollment
174
Registered
2008-02-20
Start date
2008-03-31
Completion date
2015-12-31
Last updated
2016-01-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Panic Disorder, Social Phobia

Keywords

Cognitive therapy, Stepped care, Self-help, Internet, Anxiety

Brief summary

The purpose of this study is to compare a stepped care model for the treatment of social phobia and panic disorder with standard psychological treatment. The stepped care model comprises three steps: short psycho-education, a 10 weeks Internet-based self-help program, 12 weeks individual cognitive-behavioural therapy. Patients are assessed at each step and taken out of the study if they show significant clinical improvement and follow for 12 months. Patients are randomized to either the stepped care model or standard psychological treatment, i.e. individual cognitive-behavioural therapy. All treatment components are manualized.

Interventions

BEHAVIORALindividual cognitive-behavioural therapy

1 session per week for 12 weeks

BEHAVIORALstepped care model

three steps: short psycho-education, a 10 weeks Internet-based self-help program, 12 weeks individual cognitive-behavioural therapy

Sponsors

Haukeland University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Clinical diagnoses of panic disorder or social phobia * Informed consent

Exclusion criteria

* Alcohol/drug dependency * Major depressive disorder * Psychosis * Unstable medication

Design outcomes

Primary

MeasureTime frame
Clinical Severity RatingsEnd of treatment and 12 months follow-up

Secondary

MeasureTime frame
Questionnaires: The Panic Attack Scale The Body Sensations Questionnaire The Agoraphobic Cognitions Questionnaire The Mobility Inventory for Agoraphobia Social Phobia Scale The Social Interaction Anxiety ScaleEnd of treatment and 12 months follow-up

Countries

Norway

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 17, 2026